Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Haas

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
PCR Methods and Applications|May 1, 1993
PCR-based genetic analysis of DNA from autopsied prostate tissueJ A Macoska, P D Benson, L N Turkeri, et al.
Anticancer Research|January 15, 1998
New developments in the use of cytokines for cancer therapyA Maini, P D Morse, C Y Wang, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assayG G Hillman, N Roessler, R S Fulbright, et al.
The Journal of Urology|August 1, 1993
The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patientsW A Sakr, G P Haas, B F Cassin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinomaB G Redman, G G Hillman, L Flaherty, et al.
Urologic Oncology|January 14, 2011
Immunotherapy and gene therapy for renal cell carcinomaN Nishisaka, R F Jones, A Maini, et al.
The Journal of Urology|October 1, 1984
The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinomaG P Haas, R C Klugo, F W Hetzel, et al.
Clinical and Experimental Immunology|June 1, 1994
Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinomaG G Hillman, R K Puri, M A Kukuruga, et al.
Anticancer Research|March 4, 2000
Expression of p53 and pRb in bladder and prostate cancers of patients having both cancersA Singh, R F Jones, H Friedman, et al.
The Journal of Urology|February 1, 1995
Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastasesE Younes, G P Haas, D Visscher, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
PCR Methods and Applications|May 1, 1993
PCR-based genetic analysis of DNA from autopsied prostate tissueJ A Macoska, P D Benson, L N Turkeri, et al.
Anticancer Research|January 15, 1998
New developments in the use of cytokines for cancer therapyA Maini, P D Morse, C Y Wang, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1993
Application of the direct beta counter Matrix 96 for cytotoxic assays: simultaneous processing and reading of 96 wells using a 51Cr-retention assayG G Hillman, N Roessler, R S Fulbright, et al.
The Journal of Urology|August 1, 1993
The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patientsW A Sakr, G P Haas, B F Cassin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Phase II trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinomaB G Redman, G G Hillman, L Flaherty, et al.
Urologic Oncology|January 14, 2011
Immunotherapy and gene therapy for renal cell carcinomaN Nishisaka, R F Jones, A Maini, et al.
The Journal of Urology|October 1, 1984
The synergistic effect of hyperthermia and chemotherapy on murine transitional cell carcinomaG P Haas, R C Klugo, F W Hetzel, et al.
Clinical and Experimental Immunology|June 1, 1994
Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinomaG G Hillman, R K Puri, M A Kukuruga, et al.
Anticancer Research|March 4, 2000
Expression of p53 and pRb in bladder and prostate cancers of patients having both cancersA Singh, R F Jones, H Friedman, et al.
The Journal of Urology|February 1, 1995
Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastasesE Younes, G P Haas, D Visscher, et al.
Pageof 10